Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Immune thrombocytopenia (ITP), previously called immune thrombocytopenic purpura or idiopathic thrombocytopenic purpura, is an autoimmune disorder that occurs when the body attacks its own platelets and destroys them too quickly. Platelets are a part of blood that helps control bleeding. ITP affects at least 3,000 children under the age of 16 each year in the United States.
While ITP often arises after a viral infection, for the majority of cases the cause is unknown. Luckily, acute ITP, the most common form, usually goes away on its own over the course of weeks or months, sometimes without treatment. Chronic ITP appears most frequently in adults, but occasionally is seen in children. This form of ITP is more serious, lasting for years and typically requiring specialized follow-up care.
Children and young adults with immune thrombocytopenia are treated through the Blood Disorders Center at Dana-Farber/Boston Children’s, where children and teens receive care from some of the world’s most experienced hematologists with deep experience in the conditions they treat.
Find in-depth information on immune thrombocytopenia (ITP) on the Dana-Farber/Boston Children's website, including answers to:
For information on ITP written specifically for children and teens, visit our ITP Kids pages.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”